VERSANTIS

versantis-logo

Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, is currently at preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 t... argets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcome in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.

#SimilarOrganizations #People #Financial #Event #Website #More

VERSANTIS

Social Links:

Industry:
Health Care Health Diagnostics Pharmaceutical Therapeutics

Founded:
2015-01-01

Address:
Zürich, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.versantis.ch

Total Employee:
1+

Status:
Active

Contact:
+41446330672

Email Addresses:
[email protected]

Total Funding:
21.11 M CHF

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail ReCAPTCHA Microsoft Azure DNS ReCAPTCHA V2 DomainFACTORY Hetzner DNS


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

spiraldynamik-logo

Spiraldynamik

Spiraldynamik is an anatomically based movement and therapy concept, an instruction manual for the own body from head to toe.


Current Advisors List

christopher-seaton_image

Christopher Seaton Board Member @ Versantis
Board_member
2020-09-01

peter-nicklin_image

Peter Nicklin Chairman @ Versantis
Board_member

michael-sidler_image

Michael Sidler Member of the Board @ Versantis
Board_member
2017-04-01

michael-sidler_image

Michael Sidler Board Member @ Versantis
Board_member

jean-christophe-leroux_image

Jean-Christophe Leroux Member of the Scientific Advisory Board @ Versantis
Advisor

Current Employees Featured

not_available_image

Meriam Kabbaj
Meriam Kabbaj Co-founder, Chief Operations Officer, Chairman of the Board @ Versantis
Co-founder, Chief Operations Officer, Chairman of the Board
2015-03-01

not_available_image

Vincent Forster
Vincent Forster CEO @ Versantis
CEO
2015-03-01

katharina-staufer_image

Katharina Staufer
Katharina Staufer Chief Medical Officer @ Versantis
Chief Medical Officer
2021-10-01

Founder


not_available_image

Meriam Kabbaj

Investors List

innosuisse_image

InnoSuisse

InnoSuisse investment in Grant - Versantis

swisscanto-invest_image

Swisscanto Private Equity

Swisscanto Private Equity investment in Series B - Versantis

healthequity-2_image

Healthequity

Healthequity investment in Series B - Versantis

esperante-ventures_image

Esperante Ventures

Esperante Ventures investment in Series B - Versantis

verve-ventures_image

Verve Ventures

Verve Ventures investment in Series B - Versantis

zürcher-kantonalbank_image

Zürcher Kantonal Bank

Zürcher Kantonal Bank investment in Series B - Versantis

redalpine-venture-partners_image

Redalpine

Redalpine investment in Series B - Versantis

occident-group_image

OCCIDENT

OCCIDENT investment in Series A - Versantis

healthequity-2_image

Healthequity

Healthequity investment in Series A - Versantis

zürcher-kantonalbank_image

Zürcher Kantonal Bank

Zürcher Kantonal Bank investment in Series A - Versantis

Official Site Inspections

http://www.versantis.ch

  • Host name: genlamplb002.prj-su6ko8.alias.fr.clara.net
  • IP address: 79.99.38.44
  • Location: Lambersart France
  • Latitude: 50.6453
  • Longitude: 3.0404
  • Timezone: Europe/Paris
  • Postal: 59130

Loading ...

More informations about "Versantis" on Search Engine